RECRUITING

The Effect of Prior Learning on Treatment of Morpheme Errors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a small-scale treatment study designed to determine which teaching methods result in the best learning. Treatment focuses on helping children with a developmental language disorder learn parts of grammar. Preschool children will receive assessments to determine whether they have a developmental language disorder and what parts of grammar they have not mastered. Children will receive one-on-one behavioral treatment over a six week period. Half of the children will be first taught a grammatical form they sometimes use and then one they rarely use. The other half will start with a grammatical form they rarely use. The study seeks to determine whether starting with something children sometimes use correctly (an easier part of speech) will speed later learning of something that is harder for them. The children's ability to use the grammatical forms taught to them will be assessed throughout the treatment period and approximately six weeks after treatment ends.

Official Title

The Effect of Prior Learning on Treatment of Morpheme Errors

Quick Facts

Study Start:2022-02-01
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05953077

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 6 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Native English speaking
  2. * Passed a pure-tone hearing screening
  3. * 4-6 years of age
  4. * SPELT-P2 (language) test score of \< 87
  5. * K-ABC-II Nonverbal Scale (cognition) test score of \>75
  6. * Sufficient morpheme errors to serve as treatment and control targets
  7. * Articulations skills sufficient to judge use of language targets
  8. * Able to attend treatment daily
  1. * Parent report of other handicapping conditions
  2. * Clinical signs of other disorders
  3. * Enrolled in outside treatment

Contacts and Locations

Study Contact

Elena Plante, PhD
CONTACT
520-621-5080
eplante@arizona.edu
Rebecca Vance, MS
CONTACT
520-626-9332
rbvance@arizona.edu

Study Locations (Sites)

University of Arizona
Tucson, Arizona, 85721
United States

Collaborators and Investigators

Sponsor: University of Arizona

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-01
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2022-02-01
Study Completion Date2025-04-30

Terms related to this study

Keywords Provided by Researchers

  • treatment

Additional Relevant MeSH Terms

  • Developmental Language Disorder